170 related articles for article (PubMed ID: 38042500)
1. Mechanisms of histamine release from mast cells beyond the high affinity IgE receptor in severe chronic spontaneous urticaria.
Asero R
Immunol Lett; 2024 Feb; 265():1-4. PubMed ID: 38042500
[TBL] [Abstract][Full Text] [Related]
2. Justification for IgE as a therapeutic target in chronic spontaneous urticaria.
Sánchez-Borges M; Capriles-Hulet A; Caballero-Fonseca F; González-Aveledo L
Eur Ann Allergy Clin Immunol; 2017 Jul; 49(4):148-153. PubMed ID: 28752717
[TBL] [Abstract][Full Text] [Related]
3. Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria.
Niimi N; Francis DM; Kermani F; O'Donnell BF; Hide M; Kobza-Black A; Winkelmann RK; Greaves MW; Barr RM
J Invest Dermatol; 1996 May; 106(5):1001-6. PubMed ID: 8618029
[TBL] [Abstract][Full Text] [Related]
4. The potential pharmacologic mechanisms of omalizumab in patients with chronic spontaneous urticaria.
Chang TW; Chen C; Lin CJ; Metz M; Church MK; Maurer M
J Allergy Clin Immunol; 2015 Feb; 135(2):337-42. PubMed ID: 24948369
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria.
Kaplan AP; Giménez-Arnau AM; Saini SS
Allergy; 2017 Apr; 72(4):519-533. PubMed ID: 27861988
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers of Autoimmune Chronic Spontaneous Urticaria.
Larenas-Linnemann D
Curr Allergy Asthma Rep; 2023 Dec; 23(12):655-664. PubMed ID: 38064133
[TBL] [Abstract][Full Text] [Related]
7. Omalizumab may not inhibit mast cell and basophil activation in vitro.
Gericke J; Ohanyan T; Church MK; Maurer M; Metz M
J Eur Acad Dermatol Venereol; 2015 Sep; 29(9):1832-6. PubMed ID: 25257818
[TBL] [Abstract][Full Text] [Related]
8. Complement dependence of histamine release in chronic urticaria.
Ferrer M; Nakazawa K; Kaplan AP
J Allergy Clin Immunol; 1999 Jul; 104(1):169-72. PubMed ID: 10400855
[TBL] [Abstract][Full Text] [Related]
9. Chronic urticaria: a disease at a crossroad between autoimmunity and coagulation.
Asero R; Riboldi P; Tedeschi A; Cugno M; Meroni P
Autoimmun Rev; 2007 Nov; 7(1):71-76. PubMed ID: 17967729
[TBL] [Abstract][Full Text] [Related]
10. Basophils activation of patients with chronic spontaneous urticaria in response to C5a despite failure to respond to IgE-mediated stimuli.
Matsubara D; Yanase Y; Ishii K; Takahagi S; Tanaka A; Ozawa K; Hide M
Front Immunol; 2022; 13():994823. PubMed ID: 36248902
[TBL] [Abstract][Full Text] [Related]
11. Differentiation between control subjects and patients with chronic spontaneous urticaria based on the ability of anti-IgE autoantibodies (AAbs) to induce FcεRI crosslinking, as compared to anti-FcεRIα AAbs.
Izaki S; Toyoshima S; Endo T; Kanegae K; Nunomura S; Kashiwakura JI; Sasaki-Sakamoto T; Nakamura R; Akiyama H; Ra C; Hayama K; Terui T; Okayama Y
Allergol Int; 2019 Jul; 68(3):342-351. PubMed ID: 30803853
[TBL] [Abstract][Full Text] [Related]
12. Most Patients With Autoimmune Chronic Spontaneous Urticaria Also Have Autoallergic Urticaria, but Not ViceVersa.
Xiang YK; Kolkhir P; Scheffel J; Sauer M; Vera C; Frischbutter S; Krause K; Siebenhaar F; Metz M; Maurer M; Altrichter S
J Allergy Clin Immunol Pract; 2023 Aug; 11(8):2417-2425.e1. PubMed ID: 36805105
[TBL] [Abstract][Full Text] [Related]
13. Roles of IgE and Histamine in Mast Cell Maturation.
Tanaka S; Furuta K
Cells; 2021 Aug; 10(8):. PubMed ID: 34440939
[TBL] [Abstract][Full Text] [Related]
14. Basophil Characteristics as a Marker of the Pathogenesis of Chronic Spontaneous Urticaria in Relation to the Coagulation and Complement Systems.
Yanase Y; Matsubara D; Takahagi S; Tanaka A; Ozawa K; Hide M
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373468
[TBL] [Abstract][Full Text] [Related]
15. Detection of Low-Molecular-Weight Mast Cell-Activating Factors in Serum From Patients With Chronic Spontaneous Urticaria.
Cugno M; Tedeschi A; Frossi B; Bossi F; Marzano AV; Asero R
J Investig Allergol Clin Immunol; 2016; 26(5):310-313. PubMed ID: 27763857
[TBL] [Abstract][Full Text] [Related]
16. Unveiling chronic spontaneous urticaria pathophysiology through systems biology.
Segú-Vergés C; Gómez J; Terradas-Montana P; Artigas L; Smeets S; Ferrer M; Savic S
J Allergy Clin Immunol; 2023 Apr; 151(4):1005-1014. PubMed ID: 36587849
[TBL] [Abstract][Full Text] [Related]
17. Co-occurrence of IgE and IgG autoantibodies in patients with chronic spontaneous urticaria.
Asero R; Marzano AV; Ferrucci S; Lorini M; Carbonelli V; Cugno M
Clin Exp Immunol; 2020 Jun; 200(3):242-249. PubMed ID: 32115683
[TBL] [Abstract][Full Text] [Related]
18. Treatment of chronic autoimmune urticaria with omalizumab.
Kaplan AP; Joseph K; Maykut RJ; Geba GP; Zeldin RK
J Allergy Clin Immunol; 2008 Sep; 122(3):569-73. PubMed ID: 18774392
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers and clinical characteristics of autoimmune chronic spontaneous urticaria: Results of the PURIST Study.
Schoepke N; Asero R; Ellrich A; Ferrer M; Gimenez-Arnau A; E H Grattan C; Jakob T; Konstantinou GN; Raap U; Skov PS; Staubach P; Kromminga A; Zhang K; Bindslev-Jensen C; Daschner A; Kinaciyan T; Knol EF; Makris M; Marrouche N; Schmid-Grendelmeier P; Sussman G; Toubi E; Church MK; Maurer M
Allergy; 2019 Dec; 74(12):2427-2436. PubMed ID: 31228881
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria.
Hide M; Francis DM; Grattan CE; Hakimi J; Kochan JP; Greaves MW
N Engl J Med; 1993 Jun; 328(22):1599-604. PubMed ID: 7683772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
